 | The CTD² Network in partnership with Sage Bionetworks invites the community to participate in DREAM Challenges to develop predictive bioinformatics methods. The article provides the goals and questions to address for the CTD² Pancancer Drug Activity and CTD² BeatAML DREAM Challenges. |
 | Dr. Andy Mungall is a genome scientist from British Columbia (BC) Cancer Genome Sciences Centre who is involved with molecular characterization of tumors for CGCI projects. In this interview, Dr. Mungall provides his background and perspectives on cancer genomics research. |
 | The Califano lab at Columbia University developed the OncoMatch, OncoTarget, and OncoTreat algorithms to identify effective cancer treatment therapies. The article provides an analogy of orchestra with the cells in our body and how the methods they developed would allow them to listen to the symphony, sound of the conductor. |
 | NCI’s Office of Cancer Genomics supported initiatives aim to accelerate the translational research efforts towards precision oncology. The article describes the databases and other resources available for the community. |
 | HCMI’s next-generation cancer models are associated with clinical and molecular data which are stored at NCI’s Genomic Data Commons (GDC). This article explains the types of HCMI data, generated from Cancer Model Development Centers, available at the GDC and a brief guide on how to access the data. |
No hay comentarios:
Publicar un comentario